The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
New insights into the use of currently available non-steroidal anti-inflammatory drugs
Open accessAbstract
Non-steroidal anti-inflammatory drugs (NSAIDs), which act via inhibition of the cyclooxygenase (COX) isozymes, were discovered more than 100 years ago. They remain a key component of the pharmacological management of acute and chronic pain. The COX-1 and COX-2 isozymes have different biological functions; analgesic activity is primarily (although not exclusively) associated with inhibition of COX-2, while different side effects result from the inhibition of COX-1 and COX-2. All available NSAIDs, including acetaminophen and aspirin, are associated with potential side effects, particularly gastrointestinal and cardiovascular effects, related to their relative selectivity for COX-1 and COX-2. Since all NSAIDs exert their therapeutic activity through inhibition of the COX isozymes, strategies are needed to reduce the risks associated with NSAIDs while achieving sufficient pain relief. A better understanding of the inhibitory activity and COX-1/COX-2 selectivity of an NSAID at therapeutic doses, based on pharmacokinetic and pharmacodynamic properties (eg, inhibitory dose, absorption, plasma versus tissue distribution, and elimination), and the impact on drug tolerability and safety can guide the selection of appropriate NSAIDs for pain management. For example, many NSAIDs with moderate to high selectivity for COX-2 versus COX-1 can be administered at doses that maximize efficacy (~80% inhibition of COX-2) while minimizing COX-1 inhibition and associated side effects, such as gastrointestinal toxicity. Acidic NSAIDs with favorable tissue distribution and short plasma half-lives can additionally be dosed to provide near-constant analgesia while minimizing plasma concentrations to permit recovery of COX-mediated prostaglandin production in the vascular wall and other organs. Each patient's clinical background, including gastrointestinal and cardiovascular risk factors, should be taken into account when selecting appropriate NSAIDs. New methods are emerging to assist clinicians in the selection of appropriate NSAIDs and their doses/schedules, such as biomarkers that may predict the response to NSAID treatment in individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Wolfe, M. M., Lichtenstein, D. R., & Singh, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402407 · Cited by 1,956
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Kearney, P. M., Baigent, C., Godwin, J., Halls, H., Emberson, J. R., & Patrono, C. (2006) · BMJ · doi:10.1136/bmj.332.7553.1302 · Cited by 1,445
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Tsang, A., Von Korff, M., Lee, S., Alonso, J., Karam, E., Angermeyer, M. C., Borges, G. L. G., Bromet, E. J., de Girolamo, G., de Graaf, R., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.05.005 · Cited by 1,157
McGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
García Rodríguez, L., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 975
Writing Committee Members, Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K. L., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., & Quigley, E. M. (2008) · Circulation · doi:10.1161/circulationaha.108.191087 · Cited by 843
Antman, E. M., Bennett, J. S., Daugherty, A., Furberg, C., Roberts, H., & Taubert, K. A. (2007) · Circulation · doi:10.1161/circulationaha.106.181424 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Patrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748
Goldstein, J. L., Eisen, G. M., Lewis, B., Gralnek, I. M., Zlotnick, S., & Fort, J. G. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00619-6 · Cited by 659
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
McGettigan, P., & Henry, D. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001098 · Cited by 571
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Self-citationParacetamol (Acetaminophen): mechanisms of action
ANDERSON, B. J. (2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2008.02764.x · Cited by 497
Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
Hinz, B., Cheremina, O., & Brune, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-8506com · Cited by 478
Reid, K. J., Harker, J., Bala, M. M., Truyers, C., Kellen, E., Bekkering, G. E., & Kleijnen, J. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.545813 · Cited by 476 · cited 2×
“…in whole blood after dosing with NSAIDs (COX isozyme inhibition ex vivo) and the degree of inhibition of prostanoid biosynthesis in vivo by assessing urinary levels of the major enzymatic metabolite of TxB 2 , 11-dehydro-TxB 2 , and the major metabolite of prostacyclin, 2,3-dino-6-keto-PGF 1 α .”
Reilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419
Effect of ibuprofen on cardioprotective effect of aspirin
MacDonald, T., & Wei, L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12509-3 · Cited by 419
Conaghan, P. G. (2012) · Rheumatology International · doi:10.1007/s00296-011-2263-6 · Cited by 407
Patrono, C., Patrignani, P., & Rodríguez, L. A. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13418 · Cited by 364
Self-citationvan Hecken, A., Schwartz, J. I., Depré, M., de Lepeleire, I., Dallob, A., Tanaka, W., Wynants, K., Buntinx, A., Arnout, J., Wong, P. H., et al. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001005 · Cited by 354
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial
Williams, C. M., Maher, C. G., Latimer, J., McLachlan, A. J., Hancock, M. J., Day, R. O., & Lin, C.-W. C. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60805-9 · Cited by 325
Individual NSAIDs and Upper Gastrointestinal Complications
Castellsagué, J., Riera‐Guàrdia, N., Calingaert, B., Varas‐Lorenzo, C., Fourrier‐Réglat, A., Nicotra, F., Sturkenboom, M., & Perez‐Gutthann, S. (2012) · Drug Safety · doi:10.2165/11633470-000000000-00000 · Cited by 309
García Rodríguez, L. A., Tacconelli, S., & Patrignani, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.041 · Cited by 305
Self-citationChronic diseases in the European Union: the prevalence and health cost implications of chronic pain
Leadley, R. M., Armstrong, N., Lee, Y. C., Allen, A., & Kleijnen, J. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.736933 · Cited by 282
Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding
Massó González, E. L., Patrignani, P., Tacconelli, S., & Rodríguez, L. A. G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27412 · Cited by 264
Self-citationGarcía Rodríguez, L. A., & Barreales Tolosa, L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.007 · Cited by 249
Capone, M. L., Tacconelli, S., Sciulli, M. G., Grana, M., Ricciotti, E., Minuz, P., Di Gregorio, P., Merciaro, G., Patrono, C., & Patrignani, P. (2004) · Circulation · doi:10.1161/01.cir.0000124715.27937.78 · Cited by 229
Self-citationThe COXIB Experience: A Look in the Rearview Mirror
Marnett, L. J. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145638 · Cited by 228
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
Meek, I. L., Van de Laar, M. A. F. J., & E. Vonkeman, H. (2010) · Pharmaceuticals · doi:10.3390/ph3072146 · Cited by 220
Pharmacodynamic of cyclooxygenase inhibitors in humans
Capone, M. L., Tacconelli, S., Di Francesco, L., Sacchetti, A., Sciulli, M. G., & Patrignani, P. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.019 · Cited by 190
Self-citationMcCarberg, B. H., Nicholson, B. D., Todd, K. H., Palmer, T., & Penles, L. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31818164f2 · Cited by 184
Doherty, M., Hawkey, C., Goulder, M., Gibb, I., Hill, N., Aspley, S., & Reader, S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.154047 · Cited by 160
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice
Vardeh, D., Wang, D., Costigan, M., Lazarus, M., Saper, C. B., Woolf, C. J., FitzGerald, G. A., & Samad, T. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37098 · Cited by 139
Marked Interindividual Variability in the Response to Selective Inhibitors of Cyclooxygenase-2
Fries, S., Großer, T., Price, T. S., Lawson, J. A., Kapoor, S. C., DeMarco, S., Pletcher, M. T., Wiltshire, T., & FitzGerald, G. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.002 · Cited by 138
Mode of Action of Aspirin as a Chemopreventive Agent
Dovizio, M., Bruno, A., Tacconelli, S., & Patrignani, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_3 · Cited by 137
Self-citationPharmacokinetic–pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors
Huntjens, D. R. H., Danhof, M., & Pasqua, O. E. D. (2005) · Rheumatology · doi:10.1093/rheumatology/keh627 · Cited by 126
Managing the adverse effects of nonsteroidal anti-inflammatory drugs
Patrignani, P., Tacconelli, S., Bruno, A., Sostres, C., & Lanas, Á. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.36 · Cited by 119
Self-citationRenda, G., Tacconelli, S., Capone, M. L., Sacchetta, D., SANTARELLI, F., Sciulli, M. G., Zimarino, M., Grana, M., D’Amelio, E., & Zurro, M. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.05.004 · Cited by 117
Variability in the Response to Non‐Steroidal Anti‐Inflammatory Drugs: Mechanisms and Perspectives
Bruno, A., Tacconelli, S., & Patrignani, P. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12117 · Cited by 115
Self-citationThe discovery and development of antiinflammatory drugs
Brune, K., & Hinz, B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20424 · Cited by 110
Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia
Dixon, D. A., Blanco, F. F., Bruno, A., & Patrignani, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_2 · Cited by 101
Self-citationThe Biochemical Selectivity of Novel COX-2 Inhibitors in Whole Blood Assays of COX-isozyme Activity
Tacconelli, S., Capone, M. L., Sciulli, M. G., Ricciotti, E., & Patrignani, P. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125001335 · Cited by 92
Self-citationRolf, C. G., Engström, B., Beauchard, C., Jacobs, L. D., & Liboux, A. L. (1999) · Rheumatology · doi:10.1093/rheumatology/38.6.564 · Cited by 87
THIERS, B. H. (2007) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70535-5 · Cited by 84
Brune, K. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x242584 · Cited by 82
Human Pharmacology of Naproxen Sodium
Capone, M. L., Tacconelli, S., Sciulli, M. G., Anzellotti, P., Francesco, L. D., Merciaro, G., Gregorio, P. D., & Patrignani, P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122283 · Cited by 82
Self-citationPanara, M. R., Renda, G., Sciulli, M. G., Santini, G., di Giamberardino, M., Rotondo, M. T., Tacconelli, S., Seta, F., Patrono, C., & Patrignani, P. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34895-5 · Cited by 78
Self-citationApfelbaum, J. L., Horlocker, T. T., Agarkar, M., Connis, R. T., Hebl, J. R., Nickinovich, D. G., Palmer, C. M., Rathmell, J. P., Rosenquist, R. W., & Wu, C. L. (2017) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000512001.83646.45 · Cited by 75
Atchison, J. W., Herndon, C. M., & Rusie, E. (2013) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2013.19.s9.1 · Cited by 72
Mort, J. R., Aparasu, R. R., & Baer, R. K. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.9.1307 · Cited by 69
Anzellotti, P., Capone, M. L., Jeyam, A., Tacconelli, S., Bruno, A., Tontodonati, P., Francesco, L. D., Grossi, L., Renda, G., Merciaro, G., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30175 · Cited by 65
Self-citationGastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Harewood, G. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410725 · Cited by 64
Characterization of Microsomal Prostaglandin E Synthase 1 Inhibitors
Korotkova, M., & Jakobsson, P. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12162 · Cited by 57
Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings*
Panara, M. R., Padovano, R., Sciulli, M. G., Santini, G., Renda, G., Rotondo, M. T., Pace, A., Patrono, C., & Patrignani, P. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90091-1 · Cited by 48
Self-citationGenotyping as a Tool to Predict Adverse Drug Reactions
Güzey, C., & Spigset, O. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387791 · Cited by 46
Castellsague, J., Riera‐Guàrdia, N., Calingaert, B., Varas-lorenzo, C., Fourrier-reglat, A., Nicotra, F., Sturkenboom, M., & Perez-gutthann, S. (n.d.) · Cited by 44
Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells
Sciulli, M. G., Seta, F., Tacconelli, S., Capone, M. L., Ricciotti, E., Pistritto, G., & Patrignani, P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705078 · Cited by 43
Self-citationOdom, D. M., Mladsi, D. M., Saag, K. G., Sherif, B. N., Miles, L., Ronquest, N. A., & Wang, J. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.04.012 · Cited by 38
Effect of ibuprofen on cardioprotective effect of aspirin
Etminan, M., & Samii, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13187-x · Cited by 30
Using pharmacokinetic principles to optimize pain therapy
Brune, K., Renner, B., & Hinz, B. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.141 · Cited by 29
Cardiovascular risk and COX-2 inhibition in rheumatological practice
Justice, E., & Carruthers, D. M. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001777 · Cited by 29
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology
Hinz, B., & Brune, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.004 · Cited by 26
The translational therapeutics of prostaglandin inhibition in atherothrombosis
Yu, Y., Ricciotti, E., Großer, T., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03439.x · Cited by 19
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
McQuillan, A., & Eikelboom, J. W. (2002) · New England Journal of Medicine · doi:10.1056/nejm200205163462018 · Cited by 15
Cited by
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Pharmacological properties of Salvia officinalis and its components
Ghorbani, A., & Esmaeilizadeh, M. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.12.014 · Cited by 677
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 286
Management of Osteoarthritis: Expert Opinion on NSAIDs
Magni, A., Agostoni, P., Bonezzi, C., Massazza, G., Menè, P., Savarino, V., & Fornasari, D. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00260-1 · Cited by 201
Paracetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
Metadata
- Authors
- Brune, & Patrignani, P.
- Venue
- Journal of Pain Research
- Publisher
- Informa UK Limited
- Published
- 2015-02
- Volume
- 8
- Pages
- 105
- ISSN
- 1178-7090 (ISSN-L)
- OpenAlex
- W1986137506
- Cited by
- 469
- References
- 81
- FWCI
- 22.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.